BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 11568554)

  • 1. Decreased cochlear DNA receptor staining in MRL.MpJ-Fas(lpr) autoimmune mice with hearing loss.
    Kaylie DM; Hefeneider SH; Kempton JB; Siess DC; Vedder CT; Merkens LS; Trune DR
    Laryngoscope; 2001 Jul; 111(7):1275-80. PubMed ID: 11568554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aldosterone (mineralocorticoid) equivalent to prednisolone (glucocorticoid) in reversing hearing loss in MRL/MpJ-Fas1pr autoimmune mice.
    Trune DR; Kempton JB; Kessi M
    Laryngoscope; 2000 Nov; 110(11):1902-6. PubMed ID: 11081607
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow transplantation as a strategy for the treatment of autoimmune hearing loss in MRL/Mp-lpr/lpr mice.
    Iwai H; Lee S; Inaba M; Baba S; Yamashita T; Ikehara S
    J Neuroimmunol; 2005 Nov; 168(1-2):76-82. PubMed ID: 16146652
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mineralocorticoid receptor mediates glucocorticoid treatment effects in the autoimmune mouse ear.
    Trune DR; Kempton JB; Gross ND
    Hear Res; 2006 Feb; 212(1-2):22-32. PubMed ID: 16307853
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spironolactone blocks glucocorticoid-mediated hearing preservation in autoimmune mice.
    Gross ND; Kempton JB; Trune DR
    Laryngoscope; 2002 Feb; 112(2):298-303. PubMed ID: 11889387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Orientation of three lysosomal enzymes in the mouse inner ear and hearing loss in enzyme gene deficiency].
    Guo YK; Xie DH; Yang XM
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2006 Feb; 31(1):79-84. PubMed ID: 16562682
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lymphocytic infiltration and goblet cell marker alteration in the conjunctiva of the MRL/MpJ-Fas(lpr) mouse model of Sjögren's syndrome.
    Diebold Y; Chen LL; Tepavcevic V; Ferdman D; Hodges RR; Dartt DA
    Exp Eye Res; 2007 Mar; 84(3):500-12. PubMed ID: 17208228
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation of renal tubular epithelial cell-derived interleukin-18 up-regulation with disease activity in MRL-Faslpr mice with autoimmune lupus nephritis.
    Faust J; Menke J; Kriegsmann J; Kelley VR; Mayet WJ; Galle PR; Schwarting A
    Arthritis Rheum; 2002 Nov; 46(11):3083-95. PubMed ID: 12428253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of autoimmune hearing loss in MRL/lpr mice by bone marrow transplantation.
    Lee S; Iwai H; Sugiura K; Takeuchi K; Kushida T; Tomoda K; Inaba M; Yamashita T; Ikehara S
    Bone Marrow Transplant; 2000 Oct; 26(8):887-92. PubMed ID: 11081390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of Fas-Fas ligand-mediated apoptosis in autoimmune lacrimal gland disease in MRL/MpJ mice.
    Jabs DA; Lee B; Whittum-Hudson J; Prendergast RA
    Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):399-401. PubMed ID: 11157873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inner ear DNA receptors in MRL/lpr autoimmune mice: potential 30 and 70 kDa link between autoimmune disease and hearing loss.
    Trune DR; Kempton JB; Hefeneider SH; Bennett RM
    Hear Res; 1997 Mar; 105(1-2):57-64. PubMed ID: 9083804
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Female MRL.MpJ-Fas(lpr) autoimmune mice have greater hearing loss than males.
    Trune DR; Kempton JB
    Hear Res; 2002 May; 167(1-2):170-4. PubMed ID: 12117539
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glucocorticoid impact on cochlear function and systemic side effects in autoimmune C3.MRL-Faslpr and normal C3H/HeJ mice.
    Trune DR; Kempton JB; Harrison AR; Wobig JL
    Hear Res; 2007 Apr; 226(1-2):209-17. PubMed ID: 17098384
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic determinants of autoimmune disease and coronary vasculitis in the MRL-lpr/lpr mouse model of systemic lupus erythematosus.
    Gu L; Weinreb A; Wang XP; Zack DJ; Qiao JH; Weisbart R; Lusis AJ
    J Immunol; 1998 Dec; 161(12):6999-7006. PubMed ID: 9862736
    [TBL] [Abstract][Full Text] [Related]  

  • 15. FcgammaRIIB deficiency with Fas mutation is sufficient for the development of systemic autoimmune disease.
    Yajima K; Nakamura A; Sugahara A; Takai T
    Eur J Immunol; 2003 Apr; 33(4):1020-9. PubMed ID: 12672068
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hearing in the MRL/lpr mouse as a possible model of immune-mediated sensorineural hearing loss.
    Inoue Y; Kanzaki J; Ogawa K; Hashiguchi K; Masuda M
    Eur Arch Otorhinolaryngol; 1998; 255(5):240-3. PubMed ID: 9638465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Experimental model of immune-mediated hearing loss using cross-species immunization.
    Orozco CR; Niparko JK; Richardson BC; Dolan DF; Ptok MU; Altschuler RA
    Laryngoscope; 1990 Sep; 100(9):941-7. PubMed ID: 2395402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Steroid treatment in young MRL.MpJ-Fas(lpr) autoimmune mice prevents cochlear dysfunction.
    Trune DR; Wobig RJ; Kempton JB; Hefeneider SH
    Hear Res; 1999 Nov; 137(1-2):167-73. PubMed ID: 10545644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice.
    Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B
    J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrastructural pathology in the stria vascularis of the MRL-Fasl(lpr) mouse.
    Ruckenstein MJ; Keithley EM; Bennett T; Powell HC; Baird S; Harris JP
    Hear Res; 1999 May; 131(1-2):22-8. PubMed ID: 10355601
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.